Kintara shareholders approve merger proposals; charter increase and reincorporation fail

TuHURA Biosciences, Inc./NV

Nasdaq Proposal to approve merger share issuance passed: 26.75M for, 1.18M against.
Reverse stock split (1:20-1:40) approved; Charter increase to 400M shares failed.
Reincorporation to Delaware failed; TuHURA 2024 Equity Plan and Golden Parachute approved.
Merger with TuHURA expected to close in mid-October 2024, pending remaining conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.